Title : ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways).

Pub. Date : 2018 Jun

PMID : 29426804






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 VEGF tyrosine kinase inhibitors (i.e. sorafenib or sunitinib) do not seem to significantly affect host"s susceptibility to infection, and universal anti-infective prophylaxis is not recommended either. Sorafenib vascular endothelial growth factor A Homo sapiens